Works matching IS 01435221 AND DT 2024 AND VI 138 AND IP 20

Results: 6
    1
    2

    Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD).

    Published in:
    Clinical Science, 2024, v. 138, n. 20, p. 1265, doi. 10.1042/CS20241137
    By:
    • Lopez-Pascual, Amaya;
    • Russo-Cabrera, Joan S.;
    • Ardaiz, Nuria;
    • Palmer, Tiffany;
    • Graham, Anne-Renee;
    • Uriarte, Iker;
    • Gomar, Celia;
    • Ruiz-Guillamon, David;
    • Latasa, Maria U.;
    • Arechederra, Maria;
    • Fontanellas, Antonio;
    • Monte, Maria J.;
    • Marin, Jose J. G.;
    • Berasain, Carmen;
    • del Rio, Carlos L.;
    • Fernandez-Barrena, Maite G.;
    • Martini, Paolo G. V.;
    • Schultz, Joshua R.;
    • Berraondo, Pedro;
    • Avila, Matias A.
    Publication type:
    Article
    3
    4
    5
    6